A New Grand Bargain to Improve the Antimicrobial Market for Human Health
June 27, 2022
While there have been high-level commitments from the World Health Assembly, the United Nations General Assembly (UNGA), the G20, and the G7 to tackle AMR, there has yet to be a fundamental change in how we purchase antimicrobials, or an international approach to improving access, fostering innovati...
Innovative Finance for Resettlement Working Group
May 09, 2017
The Innovative Finance for Resettlement Working Group aims to create more and better opportunities for displaced people to be safely resettled in third countries. The Working Group is developing proposals and setting out practical actions for donors and governments to use innovative financing and re...
Energy Access Targets Working Group
April 20, 2015
The Energy Access Targets Working Group will assess the current common definition of “modern energy access” and propose possible alternative targets. With at least a billion people worldwide living without electricity, and many millions more held back by blackouts and high costs, im...
The Unintended Consequences of Rich Countries’ Anti–Money Laundering Policies on Poor Countries
January 23, 2015
The Unintended Consequences of Rich Countries’ Anti-Money Laundering Policies on Poor Countries Working Group examined how rich countries might rebalance their policies to continue to protect against money laundering and terrorism financing without hindering the ability of people from poor countries...
Task Force on Regulatory Standards for Financial Inclusion
December 18, 2014
Increased financial inclusion—greater access by the poor to the use of payments, deposits, credits, insurance and risk-management services—can improve the opportunities and welfare of people living in poverty.
Intergovernmental Fiscal Transfers for Health
November 25, 2014
In many large federal or decentralized countries, the majority of public spending on health is executed by state and district governments (see graph below). Improving health in these countries—and globally—depends on improving the sufficiency, efficiency, and effectiveness of health spendi...
Drug Resistance Working Group (November 2007 – June 2010)
September 10, 2014
Value for Money: An Agenda for Global Health Funding Agencies
August 25, 2014
As international commitments become more ambitious and aid resources become increasingly constrained, global health funding agencies are seeking to improve the efficiency and impact of their investments. This growing “value for money” (VfM) agenda aims to reduce costs, increase imp...